CN1819843A - 增强脑膜炎球菌疫苗接种免疫原性的方法 - Google Patents

增强脑膜炎球菌疫苗接种免疫原性的方法 Download PDF

Info

Publication number
CN1819843A
CN1819843A CNA2004800193051A CN200480019305A CN1819843A CN 1819843 A CN1819843 A CN 1819843A CN A2004800193051 A CNA2004800193051 A CN A2004800193051A CN 200480019305 A CN200480019305 A CN 200480019305A CN 1819843 A CN1819843 A CN 1819843A
Authority
CN
China
Prior art keywords
sba
days
serogroup
titers
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800193051A
Other languages
English (en)
Chinese (zh)
Inventor
R·P·赖亚尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Publication of CN1819843A publication Critical patent/CN1819843A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNA2004800193051A 2003-05-07 2004-05-07 增强脑膜炎球菌疫苗接种免疫原性的方法 Pending CN1819843A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46858303P 2003-05-07 2003-05-07
US60/468,583 2003-05-07

Publications (1)

Publication Number Publication Date
CN1819843A true CN1819843A (zh) 2006-08-16

Family

ID=34061894

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800193051A Pending CN1819843A (zh) 2003-05-07 2004-05-07 增强脑膜炎球菌疫苗接种免疫原性的方法

Country Status (8)

Country Link
US (1) US20050002948A1 (https=)
EP (2) EP2301571A1 (https=)
JP (2) JP2007516219A (https=)
CN (1) CN1819843A (https=)
AU (2) AU2004255526A1 (https=)
BR (1) BRPI0410423A (https=)
CA (1) CA2524853A1 (https=)
WO (1) WO2005004909A2 (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102462839A (zh) * 2010-11-12 2012-05-23 北京生物制品研究所 多糖结合疫苗及其制备方法
CN103100081A (zh) * 2012-12-26 2013-05-15 天津康希诺生物技术有限公司 一种多价联合疫苗
CN106167519A (zh) * 2016-08-10 2016-11-30 成都生物制品研究所有限责任公司 一种破伤风类毒素的制备方法
CN107674118A (zh) * 2016-08-02 2018-02-09 中国食品药品检定研究院 重组蛋白PspA1、PspA2和PspA3以及包含其的多糖结合疫苗
CN109402035A (zh) * 2018-11-06 2019-03-01 华中农业大学 一种肠外致病性大肠杆菌重组菌株及其应用
CN111024946A (zh) * 2019-11-19 2020-04-17 江苏美克医学技术有限公司 阴道毛滴虫荧光免疫层析测定试剂盒及其制备方法

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371994C (en) * 1999-02-26 2010-09-28 Guido Grandi Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
GB0406013D0 (en) * 2004-03-17 2004-04-21 Chiron Srl Analysis of saccharide vaccines without interference
GB0500787D0 (en) * 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
NZ550533A (en) * 2004-04-30 2010-02-26 Novartis Vaccines & Diagnostic Meningococcal conjugate vaccination comprising N. meningitidis and diphtheria toxin
KR20070101207A (ko) * 2004-08-30 2007-10-16 사노피 파스퇴르 인크 다가 수막구균 유도체화된 다당류-단백질 접합체 및 백신
JP5135220B2 (ja) 2005-09-01 2013-02-06 ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー 血清群ｃ髄膜炎菌を含む複数ワクチン接種
BRPI0516372A (pt) * 2005-12-22 2008-09-02 Sanofi Pasteur Inc conjugados de polissacarìdeo-proteìna derivatizados meningocócicos multivalentes e vacina
EP1940462A2 (en) * 2005-12-23 2008-07-09 GlaxoSmithKline Biologicals S.A. Conjugate vaccines
KR101711903B1 (ko) * 2006-03-17 2017-03-03 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 복합 다가 면역원성 콘쥬게이트의 제조 방법
WO2007116409A2 (en) 2006-04-11 2007-10-18 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Improved vaccines comprising multimeric hsp60 peptide carriers
US7491517B2 (en) 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
US8394391B2 (en) * 2007-08-31 2013-03-12 University Of Utah Research Foundation Drug delivery vehicle that mimics viral properties
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
US8003112B2 (en) * 2009-04-16 2011-08-23 Howard University Meningococcal and pneumococcal conjugate vaccine and method of using same
CA2761733C (en) * 2009-06-01 2019-01-08 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Reagents and methods for detecting influenza virus proteins
JP2013525271A (ja) 2010-03-12 2013-06-20 チルドレンズ メディカル センター コーポレーション 免疫原およびそのスクリーニング方法
EP2575878B1 (en) * 2010-05-28 2018-06-13 Zoetis Belgium S.A. Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules
CN103648489A (zh) 2011-05-11 2014-03-19 儿童医疗中心有限公司 多抗原提呈免疫原性组合物及其方法和用途
US10428955B2 (en) * 2012-06-25 2019-10-01 Hamilton Sundstrand Corporation Contamination resistant butterfly valve
US11576958B2 (en) 2013-02-07 2023-02-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
AU2018243910B2 (en) 2017-03-28 2025-04-10 The Children's Medical Center Corporation A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
MX2019015524A (es) 2017-06-23 2020-09-10 Univ Maryland Composiciones inmunogenicas.
SG11202101973YA (en) 2018-09-12 2021-03-30 Childrens Medical Ct Corp Pneumococcal fusion protein vaccines
CN112969474A (zh) 2018-09-12 2021-06-15 艾芬尼维克斯公司 多价肺炎球菌疫苗
WO2021059181A1 (en) * 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
MX2024002779A (es) 2021-09-09 2024-06-11 Affinivax Inc Vacunas neumocócicas multivalentes.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4619828A (en) 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5422427A (en) 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
US5445817A (en) 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
US5965714A (en) 1997-10-02 1999-10-12 Connaught Laboratories, Inc. Method for the covalent attachment of polysaccharides to protein molecules
US6146902A (en) 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
CZ20024224A3 (cs) 2000-06-29 2003-05-14 Glaxosmithkline Biologicals S. A. Farmaceutický prostředek
GB0108364D0 (en) 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
SI21352A (sl) * 2001-01-23 2004-06-30 Aventis Pasteur Multivalentno meningokokno cepivo iz konjugata polisaharida-proteina

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WILLIAMS&WILKINS,BALTIMORE,: "DOSE ESCALATION,SAFETY AND IMMUNOGENICITY STUDY OF A TETRAVALENT MENINGOCOCCAL POLYSACCHARIDE DIPHTHERIA CONJUGATE VACCINE IN TODDLERS", 《PEDIATRIC INFECTIOUS DISEASE JOURNAL》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102462839A (zh) * 2010-11-12 2012-05-23 北京生物制品研究所 多糖结合疫苗及其制备方法
CN102462839B (zh) * 2010-11-12 2016-03-30 北京生物制品研究所 多糖结合疫苗及其制备方法
CN103100081A (zh) * 2012-12-26 2013-05-15 天津康希诺生物技术有限公司 一种多价联合疫苗
CN107674118A (zh) * 2016-08-02 2018-02-09 中国食品药品检定研究院 重组蛋白PspA1、PspA2和PspA3以及包含其的多糖结合疫苗
CN106167519A (zh) * 2016-08-10 2016-11-30 成都生物制品研究所有限责任公司 一种破伤风类毒素的制备方法
CN109402035A (zh) * 2018-11-06 2019-03-01 华中农业大学 一种肠外致病性大肠杆菌重组菌株及其应用
CN111024946A (zh) * 2019-11-19 2020-04-17 江苏美克医学技术有限公司 阴道毛滴虫荧光免疫层析测定试剂盒及其制备方法

Also Published As

Publication number Publication date
US20050002948A1 (en) 2005-01-06
WO2005004909A2 (en) 2005-01-20
JP2011068676A (ja) 2011-04-07
EP2301571A1 (en) 2011-03-30
CA2524853A1 (en) 2005-01-20
EP1626737A2 (en) 2006-02-22
AU2010257354A1 (en) 2011-01-20
AU2004255526A1 (en) 2005-01-20
JP2007516219A (ja) 2007-06-21
WO2005004909A3 (en) 2005-06-02
BRPI0410423A (pt) 2006-06-06

Similar Documents

Publication Publication Date Title
CN1819843A (zh) 增强脑膜炎球菌疫苗接种免疫原性的方法
CN1852733A (zh) 多价脑膜炎球菌衍生的多糖－蛋白质缀合物及疫苗
CN1191852C (zh) 疫苗
CN100350972C (zh) 含有铝佐剂和组氨酸的疫苗
CN1582297A (zh) 奈瑟球菌蛋白质的杂合和串联表达
CN1767853A (zh) 粘膜脑膜炎球菌疫苗
CN1946420A (zh) 利用蛋白质进行针对脑膜炎球菌血清群y的免疫
CN1684707A (zh) 用于细菌性脑膜炎的粘膜结合疫苗
CN1882612A (zh) 乙酰化过低和过高的脑膜炎球菌荚膜糖
CN1809380A (zh) 广泛防御高毒性脑膜炎球菌谱系的多肽－疫苗
CN101048175A (zh) 具有外膜蛋白的免疫原性细菌囊泡
CN1228709A (zh) 多价dtp－polio疫苗
US20090181054A1 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
CN101048177A (zh) 多价的脑膜炎球菌产生的多糖－蛋白质偶联物和疫苗
EP2345422A1 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
CN1993141A (zh) 诱导针对肺炎链球菌多糖的免疫应答
HK1096856A (en) Method of enhanced immunogenicity to meningococcal vaccination
HK1096305A (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and corresponding vaccines
CN1889975A (zh) 多种脑膜炎球菌血清群的液体疫苗
AU2014213504B2 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and corresponding vaccines
CN1976724A (zh) 脑膜炎球菌缀合物疫苗的整合
CN1764472A (zh) 抗多种脑膜炎球菌血清组的可注射性疫苗

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1096856

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060816

CI01 Publication of corrected invention patent application

Correction item: Rejection of patent application

Correct: Dismiss

False: Reject

Number: 32

Volume: 26

ERR Gazette correction

Free format text: CORRECT: PATENT APPLICATION REJECTION AFTER THE ANNOUNCEMENT; FROM: REJECTION TO: CANCEL REJECTION

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1096856

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20060816

WD01 Invention patent application deemed withdrawn after publication